Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenqiang Liu

Showing results (31-40 of 262) with videos related to

Pageof 27
Sort By:
Eye (London, England)|February 20, 2020
Advances in ocular drug delivery systemsJennifer J Kang-Mieler, Kayla M Rudeen, Wenqiang Liu, et al.
The Journal of Infection|December 3, 2019
Getah virus: An increasing threat in ChinaGang Lu, Ruiai Chen, Ran Shao, et al.
Methods (San Diego, Calif.)|June 7, 2018
Leveraging multiple gene networks to prioritize GWAS candidate genes via network representation learningMengmeng Wu, Wanwen Zeng, Wenqiang Liu, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 13, 2019
Berberine ameliorates diabetic neuropathic pain in a rat model: involvement of oxidative stress, inflammation, and μ-opioid receptorsJun Dong, Zhongfu Zuo, Wei Yan, et al.
Current Eye Research|March 28, 2022
Simultaneous Release of Aflibercept and Dexamethasone from an Ocular Drug Delivery SystemKayla M Rudeen, Wenqiang Liu, William F Mieler, et al.
Nanoscale|December 12, 2019
Quasi-hydrophilic black silicon photocathodes with inverted pyramid arrays for enhanced hydrogen generationShuai Zhao, Guodong Yuan, Qi Wang, et al.
Current Eye Research|October 9, 2018
Biodegradable Microsphere-Hydrogel Ocular Drug Delivery System for Controlled and Extended Release of Bioactive Aflibercept In VitroWenqiang Liu, Bao-Shiang Lee, William F Mieler, et al.
Carbohydrate Polymers|August 22, 2024
Nanostructure and interfacial mechanical properties of PEG/cellulose nanocomposites studied with molecular dynamicsWenqiang Liu, Ali Shomali, Chi Zhang, et al.
Medical Oncology (Northwood, London, England)|August 11, 2023
CRISPR screen identifies GATAD1 as a synthetic lethal target with CDK4/6 inhibitors in estrogen receptor-positive breast cancerWenqiang Liu, Ruhua Zhang, Xinhao Yu, et al.
Molecules (Basel, Switzerland)|July 25, 2018
Zinc (II)-Mediated Selective <i>O</i>-Benzylation of 2-Oxo-1,2-Dihydropyridines SystemsQifan Zhou, Fangyu Du, Xinjie Liang, et al.
Pageof 27

Showing results (31-40 of 262) with videos related to

Sort By:
Pageof 27
Eye (London, England)|February 20, 2020
Advances in ocular drug delivery systemsJennifer J Kang-Mieler, Kayla M Rudeen, Wenqiang Liu, et al.
The Journal of Infection|December 3, 2019
Getah virus: An increasing threat in ChinaGang Lu, Ruiai Chen, Ran Shao, et al.
Methods (San Diego, Calif.)|June 7, 2018
Leveraging multiple gene networks to prioritize GWAS candidate genes via network representation learningMengmeng Wu, Wanwen Zeng, Wenqiang Liu, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 13, 2019
Berberine ameliorates diabetic neuropathic pain in a rat model: involvement of oxidative stress, inflammation, and μ-opioid receptorsJun Dong, Zhongfu Zuo, Wei Yan, et al.
Current Eye Research|March 28, 2022
Simultaneous Release of Aflibercept and Dexamethasone from an Ocular Drug Delivery SystemKayla M Rudeen, Wenqiang Liu, William F Mieler, et al.
Nanoscale|December 12, 2019
Quasi-hydrophilic black silicon photocathodes with inverted pyramid arrays for enhanced hydrogen generationShuai Zhao, Guodong Yuan, Qi Wang, et al.
Current Eye Research|October 9, 2018
Biodegradable Microsphere-Hydrogel Ocular Drug Delivery System for Controlled and Extended Release of Bioactive Aflibercept In VitroWenqiang Liu, Bao-Shiang Lee, William F Mieler, et al.
Carbohydrate Polymers|August 22, 2024
Nanostructure and interfacial mechanical properties of PEG/cellulose nanocomposites studied with molecular dynamicsWenqiang Liu, Ali Shomali, Chi Zhang, et al.
Medical Oncology (Northwood, London, England)|August 11, 2023
CRISPR screen identifies GATAD1 as a synthetic lethal target with CDK4/6 inhibitors in estrogen receptor-positive breast cancerWenqiang Liu, Ruhua Zhang, Xinhao Yu, et al.
Molecules (Basel, Switzerland)|July 25, 2018
Zinc (II)-Mediated Selective <i>O</i>-Benzylation of 2-Oxo-1,2-Dihydropyridines SystemsQifan Zhou, Fangyu Du, Xinjie Liang, et al.
Pageof 27